SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Full list of Israeli high-tech layoffs in 2025

Hydrogen startup Electriq Global collapses under nearly $30M in debt, despite raising $25M

PwC integrates altshare’s algorithm to streamline startup valuations

Nice beats Q4 estimates but shares plunge on weak 2025 outlook

Buzz

Most popular

Daily

Weekly

1

Insight Partners hit by cyber attack with possible data leaks

2

CyberArk’s surge, Wiz and Cato prepare for IPOs: Israeli cyber firms ready for the next big move

3

How Intel ruined an Israeli startup it bought for $2B—and lost the AI race

4

Riskified cuts staff as struggles continue

5

Techtonic to invest over $140 million to build one of Israel's largest data centers

Richard Francis

3 stories about Richard Francis

מטה טבע כפר סבא

Teva surpasses expectations in Q4 but sets cautious outlook for 2025

29.01.25|Sophie Shulman

Despite a strong finish to the year, Teva forecasts lower-than-expected earnings and revenue growth for 2025.

ריצרד פרנסיס נשיא ו מנכל חברה חברת טב

Teva soars with double-digit growth in Q3, raises annual forecast

06.11.24|Sophie Shulman

Strong sales of Austedo and Ajovy push Teva’s revenues above expectations, with the company forecasting up to $16.5 billion in 2024.

מפגש עיתונאים ראשון עם נשיא ומנכל חברת טבע ריצ'רד פרנסיס

Teva CEO: "The company played not to lose, now we’ll play to win"

21.02.24|Sophie Shulman

Richard Francis' decision to focus on innovative drugs has boosted the stock by 40% since he took office. However, the high debt is still burdensome and the realization of the potential depends on the success of developments that are still in the laboratory